Pracownia dla Rozwojusp. z o.o.

Other human health activities not elsewhere classified

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-04-08
Share capital
5,000.00 PLN
Registered address
ul. Galileusza 12A/16, 60-159 Poznań, Poland

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 33 days early.

  • 202514/07/2026
  • 202415/07/2025
  • 202327/06/2024
  • 202214/07/2023
  • 202112/07/2022
  • 202023/04/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Human health activities2,123 / 2,927
Top 73%
Top 73%
City · Poznań9,002 / 11,727
Top 77%
Voivodeship · Wielkopolskie25,034 / 30,917
Top 81%
Country · Poland238,857 / 297,935
Top 80%

Results vs industry

Revenue
This companyUSD 30.43kMedianUSD 91.87kAverageUSD 1.38m
Net profit
This companyUSD -458.51MedianUSD 2.66kAverageUSD 145.78k
Operating costs
This companyUSD 30.88kMedianUSD 82.81kAverageUSD 1.18m
Assets
This companyUSD 2.70kMedianUSD 39.38kAverageUSD 950.01k

Authorized Representatives

Agnieszka Marta Matczyńska – Management Board Member
Rafał Jan Matczyński – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Rafał Jan Matczyńskiage 39
50$675.3150%
Others
50$675.3150%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $2,036.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$151
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$411

FAQ

Last updated: 2026-10-07